The practice of intraoperative blood salvage and autotransfusion (IBSA) during deceased donor liver transplantation (DDLT) for hepatocellular carcinoma (HCC) can potentially reduce the need for allogeneic blood transfusion. However, implementing IBSA remains debatable due to concerns about its possible detrimental effects on oncologic recurrence. Hence, a nationwide multi-center study was conducted to investigate further the association between IBSA and post-transplant HCC recurrence, including a stratified subgroup analysis.
Study Type
OBSERVATIONAL
Enrollment
998
Postoperative recurrence of liver cancer
The overall incidence of HCC recurrence (intrahepatic or extrahepatic) after LT.
Time frame: 2015.1.1-2020.12.31
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.